Keros Therapeutics Inc
KROS
$14.545+0.07 (+0.45%)
Aug 18, 2025, 3:23 PM
Financials
| 52Week High | 72.37 | 52Week Low | 9.12 |
| Beta | 1.00 | Current Ratio Annual | 21.45 |
| Current Ratio Quarterly | 21.11 | Market Cap | 586.49M |
| Net Profit Margin TTM | 8.06 | Operating Margin TTM | 0.13 |
| Price To Book | 0.83 | Price To Earnings TTM | 31.24 |
| Price To Sales TTM | 2.52 | Quick Ratio Annual | 20.61 |
| Quick Ratio Quarterly | 20.47 | Return On Assets TTM | 2.74 |
| Return On Equity TTM | 2.96 | Return On Investment TTM | 2.96 |
| Revenue Growth3Y | -43.89 | Revenue Growth5Y | -18.71 |
| Revenue Growth Quarterly Yoy | 49,002.70 | Revenue Growth TTMYoy | 85,190.84 |
| Revenue Per Share TTM | 5.73 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 165 | 1 | 1 | 8 | 3 | 0 | 38.07M | $585.35M |
| Mar 31, 2025 | 158(-4%) | 47(+4600%) | 48(+4700%) | 49(+513%) | 39(+1200%) | 19(+%) | 39.06M(+3%) | $447.25M(-24%) |
| Jun 30, 2025 | 139(-12%) | 20(-57%) | 42(-13%) | 58(+18%) | 34(-13%) | 19 | 36.85M(-6%) | $486.10M(+9%) |